Tsujimoto Hiroyuki, Hagiwara Akeo, Sugihara Hiroyuki, Hattori Takanori, Yamagishi Hisakazu
First Department of Pathology, Shiga University of Medical Science, Seta, Ohtsu, Japan.
Pathol Res Pract. 2002;198(12):785-94. doi: 10.1078/0344-0338-00337.
The INK4a/ARF locus encodes two cell cycle-regulatory proteins, p16INK4a and p14ARF. These share an exon using different reading frames, and act through Rb and p53 pathways. Recently, it has been found that silencing of p16INK4a and p14ARF expressions by aberrant methylation of the CpG islands in the promoter regions is an alternative mechanism that inactivates possible tumor suppressor functions in various tumors. To clarify the features of gastric cancers with promoter methylation of p16INK4a and p14ARF, we investigated the methylation status in gastric cancer cell lines and primary gastric cancers using methylation-specific PCR (MSP), and correlated the methylation status with microsatellite instability (MSI), DNA ploidy pattern, p53 immunohistochemistry, and various clinicopathologic factors, paying attention to the correlations with the histologic types. Of 10 cell lines studied, silencing of the expression of p16INK4a and p14ARF due to promoter methylation was detected by MSP and RT-PCR in six (60%) and two (20%) cell lines, respectively. p14ARF silencing was detected only in cell lines derived from gastric cancer of the diffuse type, while p16INK4a silencing was found in cell lines derived from both diffuse and intestinal types. In 59 primary gastric cancers, promoter methylation of p16INK4a and p14ARF was found in 10 (17%) and 14 (24%) of the tumors independently, there being an association with DNA diploidy, but not with p53 immunohistochemistry. p16INK4a methylation was found irrespective of tumor stages and histology. Whereas p14ARF methylation was found more frequently in intestinal type cancers in an early stage and in diffuse type cancers in an advanced stage, MSI tended to be related especially to p14ARF methylation in cancers of the intestinal type. Thus, the significance of p14ARF methylation differed between intestinal and diffuse types, while such a difference was not observed in p16INK4a methylation.
INK4a/ARF基因座编码两种细胞周期调节蛋白,即p16INK4a和p14ARF。它们通过不同的阅读框共用一个外显子,并通过Rb和p53途径发挥作用。最近发现,启动子区域CpG岛的异常甲基化导致p16INK4a和p14ARF表达沉默,是一种使各种肿瘤中潜在肿瘤抑制功能失活的替代机制。为了阐明p16INK4a和p14ARF启动子甲基化的胃癌特征,我们使用甲基化特异性PCR(MSP)研究了胃癌细胞系和原发性胃癌中的甲基化状态,并将甲基化状态与微卫星不稳定性(MSI)、DNA倍体模式、p53免疫组织化学以及各种临床病理因素相关联,同时关注与组织学类型的相关性。在所研究的10个细胞系中,通过MSP和RT-PCR分别在6个(60%)和2个(20%)细胞系中检测到由于启动子甲基化导致的p16INK4a和p14ARF表达沉默。仅在弥漫型胃癌来源的细胞系中检测到p14ARF沉默,而在弥漫型和肠型来源的细胞系中均发现了p16INK4a沉默。在59例原发性胃癌中,分别在10例(17%)和14例(24%)肿瘤中独立发现了p16INK4a和p14ARF的启动子甲基化,其与DNA二倍体相关,但与p53免疫组织化学无关。无论肿瘤分期和组织学如何,均发现了p16INK4a甲基化。而p14ARF甲基化在早期肠型癌和晚期弥漫型癌中更常见,MSI在肠型癌中尤其倾向于与p14ARF甲基化相关。因此,p14ARF甲基化在肠型和弥漫型中的意义不同,而p16INK4a甲基化未观察到这种差异。